ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -82.6% | 5,255 | -79.1% | 0.00% | – |
| Q2 2023 | $333 | -21.8% | 25,158 | -19.7% | 0.00% | -100.0% |
| Q1 2023 | $426 | -54.0% | 31,319 | -33.9% | 0.00% | 0.0% |
| Q4 2022 | $926 | -99.9% | 47,402 | +14.5% | 0.00% | 0.0% |
| Q3 2022 | $789,000 | -7.9% | 41,412 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $857,000 | +89.2% | 41,589 | +195.2% | 0.00% | – |
| Q1 2022 | $453,000 | -30.8% | 14,087 | +0.2% | 0.00% | -100.0% |
| Q4 2021 | $655,000 | +71.9% | 14,062 | -0.3% | 0.00% | – |
| Q3 2021 | $381,000 | -16.4% | 14,104 | -20.6% | 0.00% | – |
| Q2 2021 | $456,000 | -2.6% | 17,764 | +29.7% | 0.00% | -100.0% |
| Q1 2021 | $468,000 | +42.7% | 13,700 | +41.2% | 0.00% | – |
| Q4 2020 | $328,000 | +171.1% | 9,700 | +98.0% | 0.00% | – |
| Q3 2020 | $121,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |